EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress‐apoptosis gene expression in PBMCs of women with PCOS

Masoome Jabarpour iD, Fardin Amidi iD, Ashraf Aleyasin, Maryam Shabani Nashtaei, Mojtaba Saedi Marghmaleki

Journal of Cellular and Molecular Medicine · 2024-07 · 28 (14)

DOI: 10.1111/jcmm.18464 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 22.07.2024. Verfasst von Masoome Jabarpour und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Endoplasmic Reticulum Stress, Xanthophylls, Leukocytes, Mononuclear. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovarian syndrome (PCOS) is related to pro‐apoptotic and pro‐inflammatory conditions generated by Endoplasmic reticulum (ER) stress. This study aimed to determine the effect of Astaxanthin (ASX), as carotenoid with potent antioxidant and anti‐inflammatory properties, on serum inflammatory markers, apoptotic factors and ER stress‐apoptotic genes in peripheral blood mononuclear cells (PBMCs) of women with PCOS. This randomized, double‐blind clinical trial included 56 PCOS patients aged 18–40. For 8 weeks, subjects were randomly assigned to one of two groups: either 12 mg ASX ( n = 28) or placebo ( n = 28). Real‐time PCR was used to quantify gene expression associated with ER stress‐apoptosis in PCOS women's PBMCs. The levels of TNF‐α, IL18, IL6 and CRP were determined by obtaining blood samples from all patients before and after the intervention using Enzyme‐linked immunosorbent assay (ELISA). Also, the levels of active caspase‐3 and caspase‐8 were detected in the PBMC by ELISA kit. Furthermore, we evaluated the efficacy of ASX on disease symptoms. Following the 8‐week intervention, ASX supplementation was able to reduce the expression of GRP78 ( p = 0.051), CHOP ( p = 0.008), XBP1 ( p = 0.002), ATF4 (0.038), ATF6 (0.157) and DR5 (0.016) when compared to the placebo. However, this decrease was not statistically significant for ATF6 ( p = 0.067) and marginally significant for GRP78 ( p = 0.051). The levels of TNF‐α ( p = 0.009), IL‐18 ( p = 0.003), IL‐6 ( p = 0.013) and active caspase‐3 ( p = 0.012) were also statistically significant lower in the therapy group. However, there was no significant difference in CRP ( p = 0.177) and caspase‐8 ( p = 0.491) levels between the treatment and control groups. In our study, ASX had no significant positive effect on BMI, hirsutism, hair loss and regularity of the menstrual cycle. It appears that ASX may benefit PCOS by changing the ER stress‐apoptotic pathway and reducing serum inflammatory markers; however, additional research is required to determine this compound's potential relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeEndoplasmic Reticulum StressXanthophyllsLeukocytes, MononuclearEndoplasmic Reticulum Chaperone BiPApoptosisBiomarkersDietary SupplementsHumansFemaleAdultYoung AdultAdolescentDouble-Blind MethodGene Expression RegulationTumor Necrosis Factor-alphaInterleukin-18InflammationInterleukin-6Caspase 8

Stichwörter der Autor:innen

ER stressPBMCapoptosisastaxanthininflammatory markerspolycystic ovary syndrome

Substanzen

astaxanthineXanthophyllsEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanBiomarkersTumor Necrosis Factor-alphaInterleukin-18Interleukin-6Caspase 8

Autor:innen und Institutionen

  • Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Infertility, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Infertility, Yas Hospital, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Masoome Jabarpour, Fardin Amidi

Förderung

  • Tehran University of Medical Sciences and Health Services

Zitieren

APA

Jabarpour, M., Amidi, F., Aleyasin, A., Nashtaei, M. S., & Marghmaleki, M. S. (2024). Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress‐apoptosis gene expression in PBMCs of women with PCOS. Journal of Cellular and Molecular Medicine, 28(14). https://doi.org/10.1111/jcmm.18464

Vancouver

Jabarpour M, Amidi F, Aleyasin A, Nashtaei MS, Marghmaleki MS. Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress‐apoptosis gene expression in PBMCs of women with PCOS. Journal of Cellular and Molecular Medicine. 2024;28(14). doi:10.1111/jcmm.18464

BibTeX
@article{Jabarpour2024,
  author = {Jabarpour, Masoome and Amidi, Fardin and Aleyasin, Ashraf and Nashtaei, Maryam Shabani and Marghmaleki, Mojtaba Saedi},
  title = {Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress‐apoptosis gene expression in PBMCs of women with PCOS},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  volume = {28},
  number = {14},
  doi = {10.1111/jcmm.18464}
}
Kostenlos starten →